Testosterone deficiency could be a contributing risk factor of NASH by promoting de novo lipogenesis and hepatic inflammation as evidenced by elevated SREBP1c and FAS gene expression, and reduced PPARα expression along with the augmentation of STAT1 inflammatory signaling pathway. This evidence concerns the gene SREBF1 and metabolic dysfunction-associated steatohepatitis.